Sutro Biopharma Inc.
STRO | NASDAQ
$16.48
+$0.13 (+0.80%)
Sep 22, 2026, 1:16 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 45.7M | 99.61M | 102.48M | 105.65M | 104.47M | 66.43M | 62.04M | 160.96M | 169.36M | 154.07M | 153.73M | 48.64M | 56.87M | 74.55M | 67.77M | 69.79M | 53.16M | 53.12M | 61.88M | 59.5M | 68.81M | 50.23M |
Cost of Revenue | 1.28M | 1.28M | n/a | n/a | n/a | 1.79M | 3.55M | 3.55M | 3.55M | 43.35M | 41.59M | 84.73M | 84.73M | 43.14M | 73.13M | 59.92M | 86.52M | 111.83M | 104.4M | 97.21M | 89.97M | 81.9M |
Gross Profit | 44.42M | 98.33M | 102.48M | 105.65M | 104.47M | 64.64M | 58.49M | 157.4M | 165.81M | 110.71M | 112.14M | -36.09M | -27.86M | 31.41M | -5.35M | 9.88M | -33.36M | -58.71M | -42.52M | -37.71M | -21.16M | -31.67M |
Operating Income | -141.62M | -115.08M | -153.98M | -185.58M | -205.04M | -250.38M | -238.45M | -130.04M | -106.14M | -103.63M | -89.28M | -181.65M | -158.85M | -132.05M | -128.94M | -114.76M | -128.22M | -118.65M | -98.52M | -88.33M | -64.27M | -70.89M |
Interest Income | 6.9M | 7.7M | 9.25M | 11.58M | 36.61M | 39M | 39.91M | 40.61M | 18.12M | 16.05M | 14.51M | 12.08M | 8.54M | 5.9M | 3.46M | 1.42M | 518K | 496K | 577K | 669K | 855K | 1.06M |
Pretax Income | -180.73M | -153.72M | -191.19M | -214.43M | -206.36M | -242.85M | -225.1M | -108.14M | -106.8M | -97.16M | -88.6M | -170.07M | -142.11M | -127.25M | -116.7M | -120.24M | -131.65M | -114.29M | -105.54M | -126.96M | -78.92M | -42.89M |
Net Income | -180.64M | -153.6M | -191.09M | -216.77M | -208.7M | -245.22M | -227.46M | -123.95M | -124.45M | -114.96M | -106.79M | -172.45M | -142.66M | -130.14M | -119.2M | -122.74M | -134.15M | -114.29M | -105.54M | -126.96M | -78.92M | -42.89M |
Selling & General & Admin | 32.82M | 35.33M | 41.02M | 41.39M | 46.98M | 49.01M | 46.69M | 54.47M | 55.4M | 58.03M | 62.58M | 60.5M | 59.87M | 60.02M | 59.54M | 60.59M | 62.53M | 59.94M | 56M | 47.6M | 41.19M | 39.09M |
Research & Development | 144.74M | 151.37M | 166.42M | 200.81M | 223.07M | 246.76M | 252.04M | 234.77M | 218.33M | 197.9M | 180.43M | 169.8M | 155.84M | 146.58M | 137.17M | 123.96M | 118.85M | 111.83M | 104.4M | 97.21M | 89.97M | 81.9M |
Other Expenses | 8.48M | 26.7M | 49.02M | 49.02M | 39.47M | 19.25M | -1.79M | -1.79M | -1.79M | -41.59M | -41.59M | -84.73M | -84.73M | -43.14M | -73.13M | -59.92M | -86.52M | -111.83M | -104.4M | -94.19M | -88.05M | -81.78M |
Operating Expenses | 186.04M | 213.41M | 256.46M | 291.22M | 309.51M | 315.02M | 296.95M | 287.45M | 271.95M | 214.34M | 201.42M | 145.57M | 130.99M | 163.46M | 123.59M | 124.63M | 94.87M | 59.94M | 56M | 50.62M | 43.11M | 39.21M |
Interest Expense | 40.07M | 39.85M | 41.03M | 39.39M | 36.89M | 36.29M | 35.04M | 35.08M | 35.85M | 30.16M | 23.75M | 15.02M | 9.13M | 6.37M | 4.04M | 4.65M | 2.68M | 2.94M | 3.14M | 2.53M | 4.02M | 6.13M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -1.76M | -1.76M | -1.76M | -1.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.02M | -1.92M | -124K |
Cost & Expenses | 187.32M | 214.68M | 256.46M | 291.22M | 309.51M | 316.81M | 300.5M | 291M | 275.5M | 257.7M | 243.01M | 230.29M | 215.71M | 206.6M | 196.72M | 184.55M | 181.39M | 171.76M | 160.4M | 147.84M | 133.08M | 121.12M |
Income Tax Expense | -96K | -115K | -100K | 2.34M | 2.34M | 2.36M | 2.36M | 15.82M | 17.65M | 17.8M | 18.19M | 2.39M | 546K | 2.9M | 2.5M | 2.5M | 2.5M | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 16.57M | 13.08M | 8.58M | 8.49M | 8.46M | 8.31M | 8.25M | 8.2M | 8.12M | 6.15M | 6.1M | 6.06M | 6.03M | 5.87M | 5.68M | 5.23M | 4.7M | 4.65M | 4.6M | 4.61M | 4.61M | 4.59M |
Shares Outstanding (Diluted) | 16.57M | 13.08M | 8.58M | 8.49M | 8.46M | 8.31M | 8.25M | 8.2M | 8.12M | 6.15M | 6.1M | 6.06M | 6.03M | 5.87M | 5.68M | 5.23M | 4.7M | 4.65M | 4.62M | 4.62M | 4.61M | 4.59M |
EPS (Basic) | -17.42 | -16.49 | -22.65 | -26 | -25.20 | -29.70 | -30.10 | -16.20 | -18.40 | -18.90 | -17.90 | -29.50 | -24.80 | -23.90 | -23.80 | -25.60 | -28.90 | -24.70 | -22.90 | -30.70 | -19.40 | -8.10 |
EPS (Diluted) | -17.42 | -16.49 | -22.65 | -26 | -25.20 | -29.70 | -30.10 | -16.20 | -18.40 | -18.90 | -17.90 | -29.50 | -24.80 | -23.90 | -23.80 | -25.60 | -28.90 | -24.70 | -22.90 | -30.70 | -19.50 | -8.80 |
EBITDA | -134.6M | -106.12M | -123.94M | -148.58M | -143.11M | -183.11M | -186.81M | -69.95M | -67.9M | -62.25M | -58.04M | -148.44M | -126.67M | -114.9M | -106.98M | -110.11M | -123.81M | -106.47M | -87.07M | -71.51M | -53.3M | -66.27M |
EBIT | -140.67M | -112.82M | -131.26M | -156.15M | -150.57M | -190.47M | -194.03M | -77.03M | -74.92M | -69.21M | -64.85M | -155.05M | -132.98M | -120.88M | -112.67M | -115.58M | -128.97M | -111.35M | -91.91M | -76.22M | -57.85M | -70.76M |
Depreciation & Amortization | 6.06M | 6.7M | 7.32M | 7.57M | 7.47M | 7.36M | 7.22M | 7.08M | 7.02M | 6.96M | 6.82M | 6.61M | 6.31M | 5.98M | 5.69M | 5.48M | 5.16M | 4.88M | 4.84M | 4.7M | 4.55M | 4.49M |
Add to Watchlist
Select watchlists to add or remove STRO